Abstract
Female sexual dysfunction (FSD) is a controversial condition, which has prompted much debate regarding its aetiology, components, and even its existence. Our inability to work together as clinicians, psychologists, patients, and advocates hinders our understanding of FSD, and we will only improve matters with increased funding and collaboration.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
McCartney, M. Flibanserin for low sexual desire is not feminism. BMJ 351, h5659 (2015).
Tiefer, L., Laan, E. & Basson, R. Missed opportunities in the patient-focused drug development public meeting and scientific workshop on Female Sexual Dysfunction held at the FDA, October 2014. J. Sex Res. 52, 601–603 (2015).
Kingsberg, S. A., Clayton, A. H. & Pfaus, J. G. The female sexual response: Current models, neurobiological underpinnings and agents currently approved or under investigation for the treatment of hypoactive sexual desire disorder. CNS Drugs 29, 915–933 (2015).
Nappi, R. E. & Albani, F. Sexual dysfunction in 2015: Recovering sex drive in women – progress and opportunities. Nat. Rev. Urol. 13, 67–68 (2016).
Frühaus, S. et al. Efficacy of psychological interventions for sexual dysfunction: a systematic review and meta-analysis. Arch. Sex Behav. 42, 915–933 (2013).
Pyke, R. E. & Clayton, A. H. Psychological treatment trials for hypoactive sexual desire disorder: a sexual medicine critique and perspective. J. Sex. Med. 12, 2451–2458 (2015).
Rosen, R. C. et al. Correlates of sexually related personal distress in women with low sexual desire. J. Sex. Med. 6, 1549–1560 (2009).
Davis, S. R. et al. Androgens and Female Sexual Function and Dysfunction-Findings From the Fourth International Consultation of Sexual Medicine. J. Sex. Med. 13, 168–178 (2016).
Gao, Z. et al. Efficacy and safety of Flibanserin in women with hypoactive sexual desire disorder: a systematic review and meta-analysis. J. Sex. Med. 12, 2095–2104 (2015).
Bradford, A. & Meston, C. M. Placebo response in the treatment of women's sexual dysfunctions: a review and commentary. J. Sex. Marital Ther. 35, 164–181 (2009).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
A.G. declares that she is or has been on the advisory boards for Boehringer Ingelheim, Sandoz and Emotional Brain. She also acts as a lecturer for Pfizer and Eli Lilly, and received an unrestricted research grant from Boehringer Ingelheim. S.W. declares no competing interests.
Related links
Rights and permissions
About this article
Cite this article
Giraldi, A., Wåhlin-Jacobsen, S. Female sexual dysfunction: a call to arms for collaboration to understand the sexological elephant. Nat Rev Urol 13, 365–366 (2016). https://doi.org/10.1038/nrurol.2016.99
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrurol.2016.99
